From bench to bedside: single-cell analysis for cancer immunotherapy release_txsq3g55nnctdovkmucc52agfq

by Emily F. Davis-Marcisak, Atul Deshpande, Genevieve L. Stein-O'Brien, Won Jin Ho, Daniel Laheru, Elizabeth M. Jaffee, Elana J Fertig, Luciane Tsukamoto Kagohara

Published in Cancer Cell by Elsevier BV.

2021   Volume 39, Issue 8, p1062-1080

Abstract

Single-cell technologies are emerging as powerful tools for cancer research. These technologies characterize the molecular state of each cell within a tumor, enabling new exploration of tumor heterogeneity, microenvironment cell-type composition, and cell state transitions that affect therapeutic response, particularly in the context of immunotherapy. Analyzing clinical samples has great promise for precision medicine but is technically challenging. Successfully identifying predictors of response requires well-coordinated, multi-disciplinary teams to ensure adequate sample processing for high-quality data generation and computational analysis for data interpretation. Here, we review current approaches to sample processing and computational analysis regarding their application to translational cancer immunotherapy research.
In text/plain format

Archived Content

There are no accessible files associated with this release. You could check other releases for this work for an accessible version.

"Dark" Preservation Only
Save Paper Now!

Know of a fulltext copy of on the public web? Submit a URL and we will archive it

Type  article-journal
Stage   published
Date   2021-07-29
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  1535-6108
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f98cc570-721a-4c03-acfb-9e54c1187b71
API URL: JSON